Governmental or Regulatory Activity
CMS Selects Trulicity and Biktarvy Among 15 Drugs for Third Medicare Price Negotiation Cycle
CMS; Medicare negotiations; Trulicity; Biktarvy; drug pricing; Part B drugs; Trump administration
Trump Unveils ‘The Great Healthcare Plan’ to Lower Drug Prices and Target Insurers
Trump; Great Healthcare Plan; drug pricing; insurance premiums; price transparency; healthcare reform
Fosun Pharma’s Global Ambitions: Innovation-Driven Expansion in 2025
Fosun Pharma; global expansion; innovative drugs; 2025 results; licensing deals
Cityblock Health Appoints New CTO and Tech-Focused Board Members to Accelerate AI-Driven Care
Cityblock Health; CTO; Alberto Lopez Toledo; board members; AI; Medicaid
2025 FDA staff cuts and their impact on new drug review timelines
FDA layoffs 2025; drug review timelines; user fee programs; HHS staff cuts; RFK Jr. layoffs; PDUFA; regulatory timelines; drug approvals; FDA workforce reductions
2025 FDA staff cuts and their impact on new drug review timelines
FDA layoffs 2025; drug review timelines; user fee programs; HHS staff cuts; RFK Jr. layoffs; PDUFA; regulatory timelines; drug approvals; FDA workforce reductions
2025 FDA staff cuts and their impact on new drug review timelines
FDA layoffs 2025; drug review timelines; user fee programs; HHS staff cuts; RFK Jr. layoffs; PDUFA; regulatory timelines; drug approvals; FDA workforce reductions
2025 FDA staff cuts and their impact on new drug review timelines
FDA layoffs 2025; drug review timelines; user fee programs; HHS staff cuts; RFK Jr. layoffs; PDUFA; regulatory timelines; drug approvals; FDA workforce reductions
FDA Policy Tracker: 2025 Was a Year of Change
FDA; 2025; Trump Administration; Food Safety; FSMA 204; GRAS Reform; Drug Approvals; Recall Improvements
Drugmakers with White House MFN Deals Claim Exemption from Proposed Medicare Pricing Tests
MFN pricing; Trump administration; Medicare pricing; drug pricing deals; exemptions; pharmaceutical companies